← All Posts
Bristol-Myers Squibb Company
May 04, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
Election of Directors |
|
| 1A |
Peter J. Arduini |
✓ For(1297.46)
|
| 1B |
Deepak L. Bhatt, M.D., M.P.H., M.B.A. |
✓ For(1297.46)
|
| 1C |
Christopher S. Boerner, Ph.D. |
Withhold(1297.46)
|
| 1D |
Julia A. Haller, M.D. |
✓ For(1297.46)
|
| 1E |
Manuel Hidalgo Medina, M.D., Ph.D. |
✓ For(1297.46)
|
| 1F |
Michael R. McMullen |
✓ For(1297.46)
|
| 1G |
Paula A. Price |
✓ For(1297.46)
|
| 1H |
Derica W. Rice |
✓ For(1297.46)
|
| 1I |
Theodore R. Samuels |
✓ For(1297.46)
|
| 1J |
Karen H. Vousden, Ph.D. |
✓ For(1297.46)
|
| 1K |
Phyllis R. Yale |
✓ For(1297.46)
|
| 2 |
Advisory Vote to Approve the Compensation of our Named Executive Officers |
✓ For(1297.46)
|
| 3 |
Vote to Approve the Company's 2026 Stock Award and Incentive Plan |
✓ For(1297.46)
|
| 4 |
Ratification of the Appointment of an Independent Registered Public Accounting Firm |
✓ For(1297.46)
|
| 5 |
Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director |
✓ For(1297.46)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial